These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2926577)

  • 1. Lorazepam pharmacodynamics and pharmacokinetics in children.
    Relling MV; Mulhern RK; Dodge RK; Johnson D; Pieper JA; Rivera GK; Evans WE
    J Pediatr; 1989 Apr; 114(4 Pt 1):641-6. PubMed ID: 2926577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
    Crom WR; Relling MV; Christensen ML; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1991 Aug; 50(2):132-40. PubMed ID: 1868674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers.
    Chung JY; Cho JY; Yu KS; Kim JR; Jung HR; Lim KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2005 Jun; 77(6):486-94. PubMed ID: 15961980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.
    Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic analysis of mnesic effects of lorazepam in healthy volunteers.
    Blin O; Jacquet A; Callamand S; Jouve E; Habib M; Gayraud D; Durand A; Bruguerolle B; Pisano P
    Br J Clin Pharmacol; 1999 Oct; 48(4):510-2. PubMed ID: 10583020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterograde amnesia with oral lorazepam.
    Mac DS; Kumar R; Goodwin DW
    J Clin Psychiatry; 1985 Apr; 46(4):137-8. PubMed ID: 3980452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valproate on the pharmacokinetics and pharmacodynamics of lorazepam.
    Samara EE; Granneman RG; Witt GF; Cavanaugh JH
    J Clin Pharmacol; 1997 May; 37(5):442-50. PubMed ID: 9156377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
    Kumar R; Mac DS; Gabrielli WF; Goodwin DW
    J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterograde amnesia with oral lorazepam.
    Scharf MB; Khosla N; Lysaght R; Brocker N; Moran J
    J Clin Psychiatry; 1983 Oct; 44(10):362-4. PubMed ID: 6643396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the anti-recall effect of lorazepam: A dose--time--effect relationship.
    Pandit SK; Heisterkamp DV; Cohen PJ
    Anesthesiology; 1976 Nov; 45(5):495-500. PubMed ID: 9845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorazepam concentrations, pharmacokinetics and pharmacodynamics in a cohort of mechanically ventilated ICU patients.
    de Wit M; Best AM; Epstein SK; Greenblatt DJ
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):466-73. PubMed ID: 17063976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential amnestic properties of short- and long-acting benzodiazepines.
    Scharf MB; Khosla N; Brocker N; Goff P
    J Clin Psychiatry; 1984 Feb; 45(2):51-3. PubMed ID: 6141161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population.
    van Steveninck AL; Wallnöfer AE; Schoemaker RC; Pieters MS; Danhof M; van Gerven JM; Cohen AF
    Br J Clin Pharmacol; 1997 Sep; 44(3):267-75. PubMed ID: 9296321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.
    Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P
    Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
    Relling MV; Mulhern RK; Fairclough D; Baker D; Pui CH
    J Pediatr; 1993 Nov; 123(5):811-6. PubMed ID: 8229497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous lorazepam as an amnestic and anxiolytic agent in the intensive care unit: a prospective study.
    Deppe SA; Sipperly ME; Sargent AI; Kuwik RJ; Thompson DR
    Crit Care Med; 1994 Aug; 22(8):1248-52. PubMed ID: 8045144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.